Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Therapeutic Cancer Vaccine and Combinations With Antiangiogenic Therapies and Immune Checkpoint Blockade.

Mougel A, Terme M, Tanchot C.

Front Immunol. 2019 Mar 14;10:467. doi: 10.3389/fimmu.2019.00467. eCollection 2019. Review.

2.

High Therapeutic Efficacy of a New Survivin LSP-Cancer Vaccine Containing CD4+ and CD8+ T-Cell Epitopes.

Onodi F, Maherzi-Mechalikh C, Mougel A, Ben Hamouda N, Taboas C, Gueugnon F, Tran T, Nozach H, Marcon E, Gey A, Terme M, Bouzidi A, Maillere B, Kerzerho J, Tartour E, Tanchot C.

Front Oncol. 2018 Nov 13;8:517. doi: 10.3389/fonc.2018.00517. eCollection 2018.

3.

Therapeutic cancer vaccine: building the future from lessons of the past.

Tran T, Blanc C, Granier C, Saldmann A, Tanchot C, Tartour E.

Semin Immunopathol. 2019 Jan;41(1):69-85. doi: 10.1007/s00281-018-0691-z. Epub 2018 Jul 5. Review.

PMID:
29978248
4.

CD4/CD8/Dendritic cell complexes in the spleen: CD8+ T cells can directly bind CD4+ T cells and modulate their response.

Barinov A, Galgano A, Krenn G, Tanchot C, Vasseur F, Rocha B.

PLoS One. 2017 Jul 7;12(7):e0180644. doi: 10.1371/journal.pone.0180644. eCollection 2017.

5.

[Immune system and tumors].

Terme M, Tanchot C.

Ann Pathol. 2017 Feb;37(1):11-17. doi: 10.1016/j.annpat.2016.12.004. Epub 2017 Jan 31. Review. French.

PMID:
28159405
6.

FAM65B controls the proliferation of transformed and primary T cells.

Froehlich J, Versapuech M, Megrelis L, Largeteau Q, Meunier S, Tanchot C, Bismuth G, Delon J, Mangeney M.

Oncotarget. 2016 Sep 27;7(39):63215-63225. doi: 10.18632/oncotarget.11438.

7.

VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors.

Voron T, Colussi O, Marcheteau E, Pernot S, Nizard M, Pointet AL, Latreche S, Bergaya S, Benhamouda N, Tanchot C, Stockmann C, Combe P, Berger A, Zinzindohoue F, Yagita H, Tartour E, Taieb J, Terme M.

J Exp Med. 2015 Feb 9;212(2):139-48. doi: 10.1084/jem.20140559. Epub 2015 Jan 19.

8.

Following up tumor-specific regulatory T cells in cancer patients.

Zitvogel L, Tanchot C, Granier C, Tartour E.

Oncoimmunology. 2013 Jul 1;2(7):e25444. No abstract available.

9.

Modulation of immunity by antiangiogenic molecules in cancer.

Terme M, Colussi O, Marcheteau E, Tanchot C, Tartour E, Taieb J.

Clin Dev Immunol. 2012;2012:492920. doi: 10.1155/2012/492920. Epub 2012 Dec 24. Review.

10.

Tumor-infiltrating regulatory T cells: phenotype, role, mechanism of expansion in situ and clinical significance.

Tanchot C, Terme M, Pere H, Tran T, Benhamouda N, Strioga M, Banissi C, Galluzzi L, Kroemer G, Tartour E.

Cancer Microenviron. 2013 Aug;6(2):147-57. doi: 10.1007/s12307-012-0122-y. Epub 2012 Oct 27.

11.

Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer.

Pere H, Tanchot C, Bayry J, Terme M, Taieb J, Badoual C, Adotevi O, Merillon N, Marcheteau E, Quillien VR, Banissi C, Carpentier A, Sandoval F, Nizard M, Quintin-Colonna F, Kroemer G, Fridman WH, Zitvogel L, Oudard SP, Tartour E.

Oncoimmunology. 2012 May 1;1(3):326-333.

12.

Synergistic CD40 signaling on APCs and CD8 T cells drives efficient CD8 response and memory differentiation.

Meunier S, Rapetti L, Beziaud L, Pontoux C, Legrand A, Tanchot C.

J Leukoc Biol. 2012 Jun;91(6):859-69. doi: 10.1189/jlb.0611292. Epub 2012 Jan 11.

PMID:
22241832
13.

A CCR4 antagonist combined with vaccines induces antigen-specific CD8+ T cells and tumor immunity against self antigens.

Pere H, Montier Y, Bayry J, Quintin-Colonna F, Merillon N, Dransart E, Badoual C, Gey A, Ravel P, Marcheteau E, Batteux F, Sandoval F, Adotevi O, Chiu C, Garcia S, Tanchot C, Lone YC, Ferreira LC, Nelson BH, Hanahan D, Fridman WH, Johannes L, Tartour E.

Blood. 2011 Nov 3;118(18):4853-62. doi: 10.1182/blood-2011-01-329656. Epub 2011 Sep 9.

PMID:
21908423
14.

Increased CD127 expression on activated FOXP3+CD4+ regulatory T cells.

Simonetta F, Chiali A, Cordier C, Urrutia A, Girault I, Bloquet S, Tanchot C, Bourgeois C.

Eur J Immunol. 2010 Sep;40(9):2528-38. doi: 10.1002/eji.201040531.

15.

CD4 help regulates expression of crucial genes involved in CD8 T cell memory and sensitivity to regulatory elements.

Rapetti L, Meunier S, Pontoux C, Tanchot C.

J Immunol. 2008 Jul 1;181(1):299-308.

16.

Agonist-driven development of CD4+CD25+Foxp3+ regulatory T cells requires a second signal mediated by Stat6.

Sanchez-Guajardo V, Tanchot C, O'Malley JT, Kaplan MH, Garcia S, Freitas AA.

J Immunol. 2007 Jun 15;178(12):7550-6.

17.
18.

Homeostasis of T cell numbers: from thymus production to peripheral compartmentalization and the indexation of regulatory T cells.

Almeida AR, Rocha B, Freitas AA, Tanchot C.

Semin Immunol. 2005 Jun;17(3):239-49. Review.

PMID:
15826829
19.

CD8 T cell memory.

Rocha B, Tanchot C.

Semin Immunol. 2004 Oct;16(5):305-14. Review.

PMID:
15528075
20.

Towards a cellular definition of CD8+ T-cell memory: the role of CD4+ T-cell help in CD8+ T-cell responses.

Rocha B, Tanchot C.

Curr Opin Immunol. 2004 Jun;16(3):259-63. Review.

PMID:
15134772
21.

Immune regulation by self-reactive T cells is antigen specific.

Tanchot C, Vasseur F, Pontoux C, Garcia C, Sarukhan A.

J Immunol. 2004 Apr 1;172(7):4285-91.

22.

Mini-review CD4 T cells are required for CD8 T cell memory generation.

Bourgeois C, Tanchot C.

Eur J Immunol. 2003 Dec;33(12):3225-31. Review.

23.

Proximal changes in signal transduction that modify CD8+ T cell responsiveness in vivo.

Guillaume S, Tuosto L, Tanchot C, Di Bartolo V, Acuto O, Rocha B.

Eur J Immunol. 2003 Sep;33(9):2551-6.

24.

CD8 and B cell memory: same strategy, same signals.

Tanchot C, Rocha B.

Nat Immunol. 2003 May;4(5):431-2. No abstract available.

PMID:
12719734
25.

A role for CD40 expression on CD8+ T cells in the generation of CD8+ T cell memory.

Bourgeois C, Rocha B, Tanchot C.

Science. 2002 Sep 20;297(5589):2060-3.

26.

CD8 lethargy in the absence of CD4 help.

Bourgeois C, Veiga-Fernandes H, Joret AM, Rocha B, Tanchot C.

Eur J Immunol. 2002 Aug;32(8):2199-207.

27.
28.

Naive T cells proliferate strongly in neonatal mice in response to self-peptide/self-MHC complexes.

Le Campion A, Bourgeois C, Lambolez F, Martin B, Léaument S, Dautigny N, Tanchot C, Pénit C, Lucas B.

Proc Natl Acad Sci U S A. 2002 Apr 2;99(7):4538-43. Epub 2002 Mar 26.

29.

Adaptive tolerance of CD4+ T cells in vivo: multiple thresholds in response to a constant level of antigen presentation.

Tanchot C, Barber DL, Chiodetti L, Schwartz RH.

J Immunol. 2001 Aug 15;167(4):2030-9.

30.

Naive CD4(+) lymphocytes convert to anergic or memory-like cells in T cell-deprived recipients.

Tanchot C, Le Campion A, Léaument S, Dautigny N, Lucas B.

Eur J Immunol. 2001 Aug;31(8):2256-65.

31.

The organization of mature T-cell pools.

Tanchot C, Fernandes HV, Rocha B.

Philos Trans R Soc Lond B Biol Sci. 2000 Mar 29;355(1395):323-8. Review.

32.

The organization of mature T-cell pools.

Tanchot C, Rocha B.

Immunol Today. 1998 Dec;19(12):575-9. Review. No abstract available.

PMID:
9864949
33.

Modifications of CD8+ T cell function during in vivo memory or tolerance induction.

Tanchot C, Guillaume S, Delon J, Bourgeois C, Franzke A, Sarukhan A, Trautmann A, Rocha B.

Immunity. 1998 May;8(5):581-90.

34.

Lymphocyte homeostasis.

Tanchot C, Rosado MM, Agenes F, Freitas AA, Rocha B.

Semin Immunol. 1997 Dec;9(6):331-7. Review.

PMID:
9405261
35.
36.

Differential requirements for survival and proliferation of CD8 naïve or memory T cells.

Tanchot C, Lemonnier FA, Pérarnau B, Freitas AA, Rocha B.

Science. 1997 Jun 27;276(5321):2057-62.

37.
38.

Supplemental Content

Loading ...
Support Center